Logo image of PKI

PERKINELMER INC (PKI) Stock Price, Quote, News and Overview

NYSE:PKI - New York Stock Exchange, Inc. - US7140461093 - Common Stock - Currency: USD

115.24  -1.06 (-0.91%)

After market: 115.24 0 (0%)

PKI Quote, Performance and Key Statistics

PERKINELMER INC

NYSE:PKI (5/15/2023, 8:04:00 PM)

After market: 115.24 0 (0%)

115.24

-1.06 (-0.91%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High170
52 Week Low113.46
Market Cap14.57B
Shares126.41M
Float125.94M
Yearly DividendN/A
Dividend YieldN/A
PE14.51
Fwd PE22.11
Earnings (Next)07-31 2023-07-31/bmo
IPO07-06 1965-07-06


PKI short term performance overview.The bars show the price performance of PKI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

PKI long term performance overview.The bars show the price performance of PKI in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of PKI is 115.24 USD. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.

PERKINELMER INC / PKI Daily stock chart

PKI Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.36 203.70B
DHR DANAHER CORP 28.07 151.18B
A AGILENT TECHNOLOGIES INC 25.59 38.62B
IQV IQVIA HOLDINGS INC 17.15 33.64B
MTD METTLER-TOLEDO INTERNATIONAL 31.26 26.91B
WAT WATERS CORP 31.58 22.26B
ICLR ICON PLC 14.39 16.63B
WST WEST PHARMACEUTICAL SERVICES 31.25 15.27B
ILMN ILLUMINA INC 38.45 14.94B
RVTY REVVITY INC 23.23 13.85B
AVTR AVANTOR INC 17.3 11.78B
TEM TEMPUS AI INC N/A 10.72B

About PKI

Company Profile

PKI logo image PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.

Company Info

PERKINELMER INC

940 Winter Street

Waltham MASSACHUSETTS 02451 US

CEO: Prahlad Singh

Employees: 16700

Company Website: https://www.perkinelmer.com/

Phone: 17816635776.0

PERKINELMER INC / PKI FAQ

What is the stock price of PERKINELMER INC today?

The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.


What is the ticker symbol for PERKINELMER INC stock?

The exchange symbol of PERKINELMER INC is PKI and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is PKI stock listed?

PKI stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for PERKINELMER INC stock?

20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24. Check the PERKINELMER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PERKINELMER INC worth?

PERKINELMER INC (PKI) has a market capitalization of 14.57B USD. This makes PKI a Large Cap stock.


How many employees does PERKINELMER INC have?

PERKINELMER INC (PKI) currently has 16700 employees.


What are the support and resistance levels for PERKINELMER INC (PKI) stock?

PERKINELMER INC (PKI) has a resistance level at 127.47. Check the full technical report for a detailed analysis of PKI support and resistance levels.


Is PERKINELMER INC (PKI) expected to grow?

The Revenue of PERKINELMER INC (PKI) is expected to decline by -31.32% in the next year. Check the estimates tab for more information on the PKI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PERKINELMER INC (PKI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PERKINELMER INC (PKI) stock pay dividends?

PKI does not pay a dividend.


When does PERKINELMER INC (PKI) report earnings?

PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.


What is the Price/Earnings (PE) ratio of PERKINELMER INC (PKI)?

The PE ratio for PERKINELMER INC (PKI) is 14.51. This is based on the reported non-GAAP earnings per share of 7.94 and the current share price of 115.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for PKI.


PKI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PKI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PKI. While PKI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PKI Financial Highlights

Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.32%
ROA 5.28%
ROE 10.11%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%-33.59%
Sales Q2Q%-27.89%
EPS 1Y (TTM)-30.47%
Revenue 1Y (TTM)-3.37%

PKI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 73% to PKI. The Buy consensus is the average rating of analysts ratings from 20 analysts.

For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI


Ownership
Inst Owners86.56%
Ins Owners0.81%
Short Float %N/A
Short RatioN/A
Analysts
Analysts73
Price Target159.39 (38.31%)
EPS Next Y-34.36%
Revenue Next Year-31.32%